What is Somnee?
Somnee Sleep, developed by the Berkeley-based startup StimScience, represents a significant shift in how consumers approach sleep quality. The company's flagship Smart Sleep Headband utilizes proprietary technology to monitor brain activity and deliver personalized electrical stimulation, effectively shortening the time it takes to fall asleep and improving overall sleep architecture. As a player in the health-tech sector, Somnee distinguishes itself through a rigorous commitment to clinical validation, ensuring that its hardware-software ecosystem provides measurable improvements in user rest. The company operates at the intersection of neuroscience and consumer electronics, targeting a market segment that increasingly prioritizes data-driven health optimization over passive wellness solutions.
How much funding has Somnee raised?
Somnee has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Khosla Ventures, Seaside Ventures, and MetaLab
Key Investors in Somnee
Khosla Ventures
A prominent venture capital firm that provides strategic advice and capital to entrepreneurs building companies with lasting impact, often focusing on deep-tech and scientific breakthroughs.
Seaside Ventures
Seaside Ventures is a strategic partner in the health and wellness sector, focusing on science-driven consumer health technologies that bridge the gap between scientific breakthroughs and commercial success.
MetaLab
An interface design and product engineering firm known for its work with global tech giants, providing the design expertise necessary to translate complex technology into user-friendly consumer products.
What's next for Somnee?
With this major enterprise-level funding, Somnee is well-positioned to scale its operations and expand its market reach. The strategic capital will likely be deployed toward enhancing the device's machine learning algorithms, which power the personalization of the transcranial electrical stimulation protocols. Furthermore, the company is expected to invest in broader clinical trials to solidify its standing among medical professionals and health-conscious consumers alike. As the sleep-tech landscape becomes more competitive, Somnee's focus on proprietary neuro-stimulation technology provides a distinct competitive moat, allowing it to transition from a niche startup to a dominant force in the global sleep-improvement market.
See full Somnee company page
